Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.
about
NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cellsEpstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic miceCytokine and immunoglobulin production by PWM-stimulated peripheral and tumor-infiltrating lymphocytes of undifferentiated nasopharyngeal carcinoma (NPC) patientsEBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas.Adoptive T-Cell ImmunotherapyUnderstanding the interplay between host immunity and Epstein-Barr virus in NPC patientsEmerging treatment options for nasopharyngeal carcinomaRoles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implicationsEpstein-Barr virus antibodies and the risk of associated malignancies: review of the literatureEpstein-Barr Virus: Diseases Linked to Infection and TransformationCo-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesisEpstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J miceHLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapyEpstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma.Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients.Biology and disease associations of Epstein-Barr virus.Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of {beta}-catenin signalingThe Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitiveRedefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell linesEstablishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID miceEpithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal Src kinase.Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes.Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination.Establishment and maintenance of long-term murine gammaherpesvirus 68 latency in B cells in the absence of CD40.The Epstein-Barr virus and its association with human cancers.The role of EBV in post-transplant malignancies: a review.Id1 interacts and stabilizes the Epstein-Barr virus latent membrane protein 1 (LMP1) in nasopharyngeal epithelial cells.Epstein-Barr virus latent membrane protein-2A-induced DeltaNp63alpha expression is associated with impaired epithelial-cell differentiationThe expression and function of Epstein-Barr virus encoded latent genesEpstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinomaEpstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis.Epstein-Barr virus-encoded latent membrane protein 2A promotes the epithelial-mesenchymal transition in nasopharyngeal carcinoma via metastatic tumor antigen 1 and mechanistic target of rapamycin signaling induction.Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population.Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase.Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line.Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.
P2860
Q22254088-3F3EC64F-C5F6-4738-9E9D-81E4E1B0B685Q24524255-9A90E047-B520-4ED0-AAFB-D19CFABB1AC9Q24800020-DDA2E872-6C05-4A0E-8AC6-A239D5BEB22FQ24804219-BEF62421-7429-42AE-A0A3-8A81E840548EQ26782845-388BBD6B-0B97-459E-A40C-80E7DEEF1BE1Q26823898-4C63D516-5B57-4BEC-91FA-633E0D7EC2B5Q26995560-7979769D-DBA7-43D1-A6FE-F4B52421E615Q27009016-5863383A-E9EC-4847-864F-199A64A11697Q27021572-27EB0187-179B-43FF-8674-AC7CCD5C8CE0Q28074586-1F00D1ED-7F88-4E38-87F4-7C71A9FEAB97Q28077209-39DE6D02-AC62-417C-A750-ED3C80ECD4C0Q28594944-B7CE0991-6840-4C50-93F4-DBAECA2632B0Q30452144-ED2CAF93-DD12-41C0-BAB7-98DB1D39E820Q33305203-45FF4DAD-BC89-428C-97E2-429E7BC3B4ABQ33598586-C36155B8-3A0D-42A8-81E3-DC75A724B98FQ33653017-16FCA159-CFDC-4A80-B62C-B0D18A7B1D70Q33760249-D6548F58-9705-4E67-AE0F-158A083463A6Q33772230-53AD955C-36C4-4E6E-BBA6-7862B4058C83Q33781678-5DD48037-148B-4F89-AE31-B022A1237090Q33783746-18A93396-5B2D-4219-8389-790A6FF8F9ECQ33784685-6869E1B6-3BD0-43FA-82CD-1D7EEA1095C9Q33784983-CBB48358-991F-49E1-8D47-536DE33E2BD3Q33813796-D68DB7B2-8A4C-4DC2-ABAF-38EE0D90A19EQ33815241-F45AD98F-BE29-448A-8139-B8CCDCB66595Q33821583-4AD03A23-A43C-42AC-AFE5-D432A650D767Q33825567-6A761D34-5D38-4ADB-90B1-9BD8319588B1Q33834753-E4554991-2C0F-48E1-A017-416548684D43Q33882153-F152B483-5EAF-4353-9D33-6F48681B25B3Q33925488-F1A00167-B310-4853-994B-EB0859CE1794Q33942005-B71294E6-0CCA-406F-BF80-D72B85155B02Q34029669-29431F96-B829-469D-8328-2D38DF94D20CQ34089485-2CF9BB63-0DC5-472C-9008-B2F8A6728A6AQ34089491-C7309650-4590-492A-8B7D-D6253900EE38Q34228703-A840466C-38D0-4553-B4D0-96ED1AD85CE0Q34261571-E096484A-DB28-4458-AFB1-9E3C25942423Q34286259-23AA999B-26C8-4303-B139-AE777B1656A2Q34302121-761160E4-82D2-49B2-8858-AD00E1304188Q34344427-8BFF7628-43D5-403B-9E78-9BDE38B830CDQ34502958-34133932-0816-4065-A01D-6CFC5C7ADCD4Q34611577-752A249A-1173-4DAE-866E-CF86B7F25857
P2860
Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Epstein-Barr virus latent gene ...... 1, LMP1, and LMP2 transcripts.
@ast
Epstein-Barr virus latent gene ...... 1, LMP1, and LMP2 transcripts.
@en
type
label
Epstein-Barr virus latent gene ...... 1, LMP1, and LMP2 transcripts.
@ast
Epstein-Barr virus latent gene ...... 1, LMP1, and LMP2 transcripts.
@en
prefLabel
Epstein-Barr virus latent gene ...... 1, LMP1, and LMP2 transcripts.
@ast
Epstein-Barr virus latent gene ...... 1, LMP1, and LMP2 transcripts.
@en
P2093
P2860
P1433
P1476
Epstein-Barr virus latent gene ...... 1, LMP1, and LMP2 transcripts.
@en
P2093
P2860
P304
P407
P577
1992-05-01T00:00:00Z